Nano Labs Ltd. declined 1.20% in after-hours trading. The company announced a partnership with Hawkeye Bio and Ease Healthcare to develop a novel lung cancer screening product, LEAP, which is a non-invasive, radiation-free, and highly sensitive blood test designed to detect early signs of lung cancer.
Comments
No comments yet